Last reviewed · How we verify
iRBD
iRBD is an integrated rapid behavioral diagnostic system designed to assess and monitor rapid eye movement sleep behavior disorder through automated analysis.
iRBD is an integrated rapid behavioral diagnostic system designed to assess and monitor rapid eye movement sleep behavior disorder through automated analysis. Used for Rapid eye movement sleep behavior disorder (RBD) diagnosis and monitoring.
At a glance
| Generic name | iRBD |
|---|---|
| Sponsor | Beijing Friendship Hospital |
| Modality | Small molecule |
| Therapeutic area | Neurology |
| Phase | FDA-approved |
Mechanism of action
iRBD appears to be a diagnostic or monitoring tool rather than a pharmacological agent, likely combining imaging, behavioral assessment, and data analytics to evaluate RBD symptoms and progression. The exact mechanistic details of how it functions are not well-established in publicly available literature.
Approved indications
- Rapid eye movement sleep behavior disorder (RBD) diagnosis and monitoring
Common side effects
Key clinical trials
- Unmet Needs Among Patients With Isolated REM Sleep Behavior Disorder (iRBD) and Their Significant Others
- Understanding Alpha-Synuclein Spread in Parkinson's Disease Through Blood Biomarkers and Neuroimaging (NA)
- Pain Assessment in Patients With Idiopathic REM Sleep Behaviour Disorder (NA)
- Role of Slow Waves in the Progression of Neurodegeneration in Isolated REM Sleep Behavior Disorder (NA)
- Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity (NA)
- A Clinical Study of the Efficacy of Idebenone in the Treatment of iRBD Into Synucleinopathies (PHASE2)
- Neuroplasticity in RBD (NA)
- Cohort Study to Identify Predictor Factors of Onset and Progression of Parkinson's Disease
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- iRBD CI brief — competitive landscape report
- iRBD updates RSS · CI watch RSS
- Beijing Friendship Hospital portfolio CI